Table 1 Baseline characteristics
| Variables | N (%)/mean ± SD |
|---|---|
| Age (years) | 62.8 ± 9.1 |
| Patients | 31 |
| Sex (m/f) | 21 (67.8%) / 10 (32.2%) |
| Number of tumors (ablated/resected) | 98 (42/56) |
| Tumor size of ablated lesions | 15.1 ± 7.6 mm |
| Tumor size of resected lesions | 28.7 ± 23.0 mm |
| Tumor entity | HCC (n = 7) |
| iCCA (n = 1) | |
| Metastases (n = 23) | |
| Colorectal carcinoma (n = 17) | |
| - Left sided (n = 13) | |
| - Right sided (n = 4) | |
| Uveal melanoma (n = 3) | |
| Malignant melanoma (n = 1) | |
| Breast cancer (n = 1) | |
| Neuroendocrine tumor (n = 1) | |
| Concomitant liver cirrhosis | 5/31 (16.1%); Child A: n = 3, Child B: n = 2 |
| Liver function (serum levels): | |
| GOT/GPT (U/I) | 45.2 ± 39.0 / 47.5 ± 43.7 |
| Bilirubin (mg/dl) | 0.6 ± 0.3 |
| Quick-Test (%) | 96.6 ± 13.9 |